A detailed history of Pathstone Holdings, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 16,671 shares of TMDX stock, worth $1.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,671
Previous 26,381 36.81%
Holding current value
$1.2 Million
Previous $4.14 Million 74.91%
% of portfolio
0.0%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$59.28 - $144.9 $575,608 - $1.41 Million
-9,710 Reduced 36.81%
16,671 $1.04 Million
Q3 2024

Nov 07, 2024

BUY
$135.68 - $176.11 $167,022 - $216,791
1,231 Added 4.89%
26,381 $4.14 Million
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $634,771 - $1.32 Million
8,741 Added 53.27%
25,150 $3.79 Million
Q1 2024

May 13, 2024

BUY
$70.86 - $89.93 $887,308 - $1.13 Million
12,522 Added 322.15%
16,409 $1.21 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $142,808 - $315,157
3,887 New
3,887 $306,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.29B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.